These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 11798827)
1. [Effect of hydroxyurea combined with interferon-alpha on growth and apoptosis-related oncogene expression of K562 cells]. Chen H; Luo Z; Luo S Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):606-9. PubMed ID: 11798827 [TBL] [Abstract][Full Text] [Related]
2. [Effects of IFN-alpha combined with IL-6 on cell growth and related genes expression and apoptosis of bone marrow cells from CGL patients]. Chen H; Tang L; Peng X; Luo Z; Luo S; Tan W Zhonghua Xue Ye Xue Za Zhi; 2000 Jul; 21(7):341-4. PubMed ID: 11877000 [TBL] [Abstract][Full Text] [Related]
3. [Influence of IFN-alpha and IFN-alpha combined with GM-CSF on expression of the genes related to cell apoptosis of MNCs from bone marrow in CML patients]. Tang LJ; Chen HC; Peng XH Hunan Yi Ke Da Xue Xue Bao; 2000 Dec; 25(6):570-2. PubMed ID: 12516408 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of interferon-alpha receptor expression in hydroxyurea-treated leukemia cell lines. Tamura T; Matsuzaki M; Harada H; Ogawa K; Mohri H; Okubo T J Investig Med; 1997 Apr; 45(4):160-7. PubMed ID: 9154296 [TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib. Zhang GS; Liu DS; Dai CW; Li RJ Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520 [TBL] [Abstract][Full Text] [Related]
6. [Different sensitivity of two chronic myeloid leukemia cell lines to interferon-alpha]. Li XM; Chen HC; Liu XF; Wu YH; Cao YF Ai Zheng; 2003 Oct; 22(10):1047-52. PubMed ID: 14558948 [TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells. Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377 [TBL] [Abstract][Full Text] [Related]
8. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells]. Wang S; Chai YB; Liu F; Zhang XY; Jia W; Xie X; Yu WQ; Shang ZC; Jin BQ; Sun BZ Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):198-202. PubMed ID: 15854468 [TBL] [Abstract][Full Text] [Related]
9. Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines. Yano H; Iemura A; Haramaki M; Ogasawara S; Takayama A; Akiba J; Kojiro M Hepatology; 1999 Jun; 29(6):1708-17. PubMed ID: 10347112 [TBL] [Abstract][Full Text] [Related]
10. IFN-alpha enhances TNF-alpha-induced apoptosis through down-regulation of c-Myc protein expression in HL-60 cells. Nakashima A; Kumakura S; Mishima S; Ishikura H; Kobayashi S J Exp Clin Cancer Res; 2005 Sep; 24(3):447-56. PubMed ID: 16270532 [TBL] [Abstract][Full Text] [Related]
11. Apoptotic effect of As2S2 on K562 cells and its mechanism. Li JE; Wu WL; Wang ZY; Sun GL Acta Pharmacol Sin; 2002 Nov; 23(11):991-6. PubMed ID: 12421474 [TBL] [Abstract][Full Text] [Related]
12. Depsipeptide enhances imatinib mesylate-induced apoptosis of Bcr-Abl-positive cells and ectopic expression of cyclin D1, c-Myc or active MEK abrogates this effect. Kawano T; Horiguchi-Yamada J; Iwase S; Akiyama M; Furukawa Y; Kan Y; Yamada H Anticancer Res; 2004; 24(5A):2705-12. PubMed ID: 15517875 [TBL] [Abstract][Full Text] [Related]
13. [Effect on bcr-abl signaling pathway and the mechanisms of apoptosis induction by meisoindigo in K562 cells]. Liu BC; Xiao ZJ Zhonghua Xue Ye Xue Za Zhi; 2008 Dec; 29(12):815-8. PubMed ID: 19176035 [TBL] [Abstract][Full Text] [Related]
14. [New insight into the mechanism of p53 inducing leukemia cell apoptosis]. Chen YZ; Wu Y; Liang M; Li NN; Zhang ZX; Lu LH Zhonghua Xue Ye Xue Za Zhi; 2003 Dec; 24(12):640-3. PubMed ID: 14761612 [TBL] [Abstract][Full Text] [Related]
15. Multigene targeting with antisense oligodeoxynucleotides: an exploratory study using primary human leukemia cells. Opalinska JB; Machalinski B; Ratajczak J; Ratajczak MZ; Gewirtz AM Clin Cancer Res; 2005 Jul; 11(13):4948-54. PubMed ID: 16000594 [TBL] [Abstract][Full Text] [Related]
16. Suppression of bcr-abl synthesis by siRNAs or tyrosine kinase activity by Glivec alters different oncogenes, apoptotic/antiapoptotic genes and cell proliferation factors (microarray study). Zhelev Z; Bakalova R; Ohba H; Ewis A; Ishikawa M; Shinohara Y; Baba Y FEBS Lett; 2004 Jul; 570(1-3):195-204. PubMed ID: 15251464 [TBL] [Abstract][Full Text] [Related]
17. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation. Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172 [TBL] [Abstract][Full Text] [Related]
18. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis. Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329 [TBL] [Abstract][Full Text] [Related]
19. Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells. Kondo M; Nagano H; Wada H; Damdinsuren B; Yamamoto H; Hiraoka N; Eguchi H; Miyamoto A; Yamamoto T; Ota H; Nakamura M; Marubashi S; Dono K; Umeshita K; Nakamori S; Sakon M; Monden M Clin Cancer Res; 2005 Feb; 11(3):1277-86. PubMed ID: 15709199 [TBL] [Abstract][Full Text] [Related]
20. [Synergism of As2S2 and STI 571 in inducing apoptosis of K562 cells]. Li JE; Sun GL; Wu YL; Wu WL Zhonghua Xue Ye Xue Za Zhi; 2003 Nov; 24(11):580-3. PubMed ID: 14720443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]